Athletic Greens Partners with The Surf Lodge for a Summer of Health and Wellness Programming

Nina Agdal, Joe Holder and More to Join AG1 Team for Weekend Wellness Events at Montauk, NY Resort NEW YORK–(BUSINESS WIRE)–Athletic Greens, originators of the Foundational Nutrition category and creators of the daily nutrition drink AG1, announced today its partnership with The Surf Lodge, a hotel, restaurant and bar in Montauk, New York, for a … [Read more…]

Global Infrared Thermometers Market Trajectory & Analytics Report 2022: Market to Reach $1.3 Billion by 2026 – US and Europe Dominate, Asia-Pacific to Witness the Fastest Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Infrared Thermometers – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering. Global Infrared Thermometers Market to Reach $1.3 Billion by 2026 Amid the COVID-19 crisis, the global market for Infrared Thermometers estimated at US$752.5 Million in the year 2020, is projected to reach a revised size of US$1.3 Billion … [Read more…]

Curio Digital Therapeutics Partners with Axia Women’s Health To Support Patients with Postpartum Depression

The Newly Launched MamaLift Program Provides Mental Health Support for Expecting and New Mothers Across Multiple States PRINCETON, N.J.–(BUSINESS WIRE)–Curio Digital Therapeutics and Axia Women’s Health, one of the nation’s largest independent women’s health groups, are pleased to announce a collaboration agreement to help women at risk for postpartum depression and those diagnosed with postpartum … [Read more…]

Seres Therapeutics Announces $100 Million Registered Direct Offering of Common Stock

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome therapeutics company, today announced that it has entered into securities purchase agreements with new and existing investors and certain directors and officers in a registered direct offering of 31,746,030 shares of common stock (the “Shares”) at a purchase price of $3.15 per share, resulting in … [Read more…]

Radiometer and Etiometry Announce Partnership to Enhance Neonatal Intensive Care Clinical Workflows and Patient Outcomes

Leading Intensive Care Clinical Decision-Support Software and Acute Care Diagnostics Medical Device Provider Announce Partnership BOSTON & BREA, Calif.–(BUSINESS WIRE)–#Etiometry—Etiometry, a leader in clinical decision-support software for critical care, and Radiometer, a leading medical device company specializing in acute care testing solutions, today announced a new collaboration to enhance the clinical workflows in Neonatal Intensive … [Read more…]

Madison Core Laboratories Welcomes New Chief Financial Officer

HUNTSVILLE, Ala.–(BUSINESS WIRE)–#diagnostics–Madison Core Laboratories, LLC (MCL) announces the appointment of Jerry C. Smith, a seasoned financial executive, as Chief Financial Officer (“CFO”). Smith brings to MCL a CPA background and over 25 years of experience in finance, accounting, revenue cycle management, and mergers and acquisitions in multiple sectors of healthcare and technology. He most … [Read more…]

PureTech Initiates Late-Stage Clinical Study of Wholly-Owned Candidate LYT-100 (Deupirfenidone) in IPF and Advances LYT-200 (Anti-Galectin-9 mAb)

IPF study will evaluate efficacy of two doses of LYT-100, one with comparable exposure to FDA-approved dose of pirfenidone and one with higher exposure, vs. placebo, as well as relative tolerability and efficacy vs. pirfenidone Bi-monthly, monotherapy dose escalation portion of Phase 1/2 study of LYT-200 for the potential treatment of solid tumors has completed; … [Read more…]

Aura Biosciences Receives FDA Fast Track Designation for Belzupacap Sarotalocan (AU-011) for the Treatment of Non-Muscle Invasive Bladder Cancer

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing a novel class of virus-like drug conjugate (VDC) therapies for multiple oncology indications, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for belzupacap sarotalocan (AU-011), Aura’s first VDC product candidate, for the treatment of Non-Muscle Invasive … [Read more…]

IMFINZI® (durvalumab) Plus Chemotherapy Significantly Improved Pathologic Complete Response in AEGEAN Phase III Trial in Resectable Non-Small Cell Lung Cancer

Trial will continue to assess additional primary endpoint of event-free survival WILMINGTON, Del.–(BUSINESS WIRE)–Positive high-level results from a planned interim analysis of the AEGEAN Phase III trial showed treatment with AstraZeneca’s IMFINZI® (durvalumab) in combination with neoadjuvant chemotherapy before surgery demonstrated a statistically significant and meaningful improvement in pathologic complete response (pCR) compared to neoadjuvant … [Read more…]

Alto Pharmacy Appoints Alicia Boler Davis as CEO to Drive Next Phase of Growth

Alicia Boler Davis brings more than 25 years of experience leading world-class technology operations SAN FRANCISCO–(BUSINESS WIRE)–Alto Pharmacy today announced Alicia Boler Davis will become CEO on September 1, 2022. Alicia was recruited by co-founders and current co-CEOs Jamie Karraker and Matt Gamache-Asselin to scale the business that is transforming a $500 billion industry by … [Read more…]